BioWorld MedTech

Feb. 19, 2015

View Archived Issues

SAVI Scout touted as something surgeons have 'fantasized about'

Inside the Beltway: FDA unveils preliminary agenda for NGS regs, but no talks yet with CMS

Financings:Lineagen closes on second, final tranche of Series C funding round

Daily M&A: TE to acquire AdvancedCath for $190 million in cash deal

World in Review: AirStrip and Life Monitor partner will launch AirStrip in Australia

Agreements/contracts: OncoSec, Heat to evaluate efficacy of ImmunoPulse

HIT Bits: IOD has successful testing of its PRISM platform

Patent Watch: AdvaStim Expands IP with new U.S. neurostimulation patent

People in Places

Medtronic launches Euphora catheter, makes progress with artificial pancreas

Medtronic (Dublin) reported the launch of the Euphora Semicompliant Balloon Dilatation Catheter in countries that recognize the CE mark. The first patient case with the Euphora Semicompliant Balloon Catheter was recently performed by Richard Edwards, consultant cardiologist at the Freeman Hospital in Newcastle, UK. Read More

Report from Europe: HIFU study results fuels commercial drive for Theraclion's EchoPulse

Product briefs

MDD's Orthopedics Extra

Today's news in brief

BioWorld

BioWorld briefs for June 12, 2026.

Ethyreal launches to treat the underlying cause of Graves’, TED

BioWorld

Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...

Microbiota modulates the antidepressant effects of GLP-1 analogues

BioWorld Science

Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...

EHA 2026: With new lenses, a changing view on pediatric cancers

BioWorld

In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...

Microscopic image of chronic myeloid leukemia

Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid

BioWorld

Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...